Research Paper
Transcutaneous Peripheral Nerve Stimulation for Essential Tremor: A Randomized Clinical Trial
JAMA Neurology12/1/2025·12/01/25🌐 USA
Summary
This randomized sham-controlled trial evaluated a wearable neuromodulation device delivering transcutaneous peripheral nerve stimulation to radial, median, and ulnar nerves for essential tremor. At 90 days, the active treatment group showed a 6.9-point reduction in Activities of Daily Living scores versus 2.7 points for sham.
Why it matters
This non-invasive, AI-adjusted wearable device offers a promising alternative to pharmacological and surgical tremor treatments. The positive results could expand treatment options for the millions of patients with essential tremor who are unsatisfied with current therapies.
#Non-invasive#Wearables#Parkinson's#Neurostimulation
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in